AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Low-Level Laser Therapy in the Treatment of Trigger Finger

RecruitingNAAges 18 Years - anyAllDokuz Eylul University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Trigger finger, also known as stenosing tenosynovitis, is one of the most common disorders affecting the hand. Its lifetime prevalence is 2-3%. Patients typically present with locking of the affected finger during flexion and painful catching during extension. In mild cases, pain, swelling, and morning stiffness may be present without triggering. In more severe cases, the affected finger may become locked in flexion. Conservative treatment methods, corticosteroid injections, and surgical interventions can be used in the treatment of trigger finger. Conservative treatment options include activity modification, splint immobilization, exercise programs, massage, physical therapy modalities including extracorporeal shock wave therapy and therapeutic ultrasound, and nonsteroidal anti-inflammatory drugs (NSAIDs). Splinting is an inexpensive and effective treatment option for trigger finger.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Applying to the outpatient clinic of the Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Dokuz Eylรผl University * A clinical diagnosis of trigger finger based on typical pain and tenderness over the A1 pulley accompanied by triggering of the affected finger * Willingness to participate in the study Exclusion Criteria: * Multiple trigger fingers in the same hand * Fixed deformity (Quinnell grade 4) * Splint treatment, physical therapy, or steroid injection for the affected trigger finger within the previous 6 months * Previous surgery for the affected trigger finger * Musculoskeletal disorders or peripheral nerve injury involving the ipsilateral upper extremity * Rheumatoid arthritis, carpal tunnel syndrome, Dupuytren disease, amyloidosis, or mucopolysaccharidosis * Active infection, bleeding, skin lesions, or an implant at the treatment site * Radiotherapy within the previous 6 months * Photodermatosis, photosensitivity, or systemic lupus erythematosus * Pregnancy, epilepsy, coagulopathy, active malignancy, or the presence of a cardiac pacemaker * Cognitive impairment that precludes understanding of the study questionnaires.
๐Ÿ’Š

What it tests

  • Low Level Laser Therapy
  • Sham Low Level Laser Therapy
๐Ÿ“

Where

1 site
Dokuz Eylul University
Izmir, Turkey (Tรผrkiye)
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy